These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 16541418

  • 1. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
    Lu S, Dong Z.
    Prostate; 2006 Jun 15; 66(9):996-1004. PubMed ID: 16541418
    [Abstract] [Full Text] [Related]

  • 2. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 3. Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide.
    Wang D, Lu S, Dong Z.
    Prostate; 2007 Dec 01; 67(16):1825-33. PubMed ID: 17941092
    [Abstract] [Full Text] [Related]

  • 4. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 5. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY, Zelner DJ, Lee C.
    Exp Cell Res; 1998 May 25; 241(1):151-60. PubMed ID: 9633523
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 25; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Signal of proteinase-activated receptor-2 contributes to highly malignant potential of human pancreatic cancer by up-regulation of interleukin-8 release.
    Ikeda O, Egami H, Ishiko T, Ishikawa S, Kamohara H, Hidaka H, Takahashi M, Ogawa M.
    Int J Oncol; 2006 Apr 25; 28(4):939-46. PubMed ID: 16525644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.
    Karlsson G, Liu Y, Larsson J, Goumans MJ, Lee JS, Thorgeirsson SS, Ringnér M, Karlsson S.
    Physiol Genomics; 2005 May 11; 21(3):396-403. PubMed ID: 15769904
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F, Strand DW, Rowley DR.
    Oncogene; 2008 Jan 17; 27(4):450-9. PubMed ID: 17637743
    [Abstract] [Full Text] [Related]

  • 12. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X, Bellis S, Yan Z, Friedman E.
    Cell Growth Differ; 1999 Jan 17; 10(1):11-8. PubMed ID: 9950213
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.
    Barrett JM, Rovedo MA, Tajuddin AM, Jilling T, Macoska JA, MacDonald J, Mangold KA, Kaul KL.
    Prostate; 2006 May 01; 66(6):632-50. PubMed ID: 16388503
    [Abstract] [Full Text] [Related]

  • 14. Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-beta 1.
    Liu G, Zhang F, Lee J, Dong Z.
    Cytokine; 2005 Aug 07; 31(3):241-9. PubMed ID: 15975819
    [Abstract] [Full Text] [Related]

  • 15. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T, Kobayashi H, Wakahara K, Matsuzaki H, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T.
    FEBS Lett; 2004 Oct 22; 576(3):408-16. PubMed ID: 15498571
    [Abstract] [Full Text] [Related]

  • 16. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG.
    J Cell Physiol; 1998 Aug 22; 176(2):424-34. PubMed ID: 9648930
    [Abstract] [Full Text] [Related]

  • 17. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N, Imai J, Watanabe M, Hiroi N, Sugano S, Yoshino G.
    Horm Metab Res; 2006 Mar 22; 38(3):159-66. PubMed ID: 16673206
    [Abstract] [Full Text] [Related]

  • 18. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C.
    Cancer Res; 1996 Jan 01; 56(1):44-8. PubMed ID: 8548772
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A, Davis BH, Sitrin MD, Brasitus TA, Bissonnette M.
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct 01; 283(4):G864-74. PubMed ID: 12223346
    [Abstract] [Full Text] [Related]

  • 20. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D, Tang XM, Ma C, Chegini N.
    Gynecol Oncol; 2001 May 01; 81(2):301-9. PubMed ID: 11330966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.